Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?

被引:57
作者
Chan, Yau-Tuen [1 ]
Wang, Ning [1 ]
Tan, Hor Yue [1 ]
Li, Sha [1 ]
Feng, Yibin [1 ]
机构
[1] Univ Hong Kong, Sch Chinese Med, Hong Kong, Peoples R China
关键词
hepatic stellate cells; liver fibrosis; cirrhosis; natural product; herbal medicine; network pharmacology; SALVIANOLIC ACID-B; NF-KAPPA-B; GROWTH-FACTOR; RAT-LIVER; TGF-BETA; SIGNALING PATHWAY; IN-VIVO; COLLAGEN PRODUCTION; GLYCYRRHIZIC ACID; TISSUE INHIBITOR;
D O I
10.3389/fphar.2020.00548
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Liver fibrosis is a progressive liver damage condition that is worth studying widely. It is important to target and alleviate the disease at an early stage before turning into later cirrhosis or liver cancer. There are currently no direct medicines targeting the attenuation or reversal of liver fibrosis, and so there is an urgent need to look into this area. Traditional Chinese Medicine has a long history in using herbal medicines to treat liver diseases including fibrosis. It is time to integrate the ancient wisdom with modern science and technology to look for the best solution to the disease. In this review, the principal concept of the pathology of liver fibrosis will be described, and then some of the single compounds isolated from herbal medicines, including salvianolic acids, oxymatrine, curcumin, tetrandrine, etc. will be discussed from their effects to the molecular mechanism behind. Molecular targets of the compounds are analyzed by network pharmacology approach, and TGF beta/SMAD was identified as the most common pathway. This review serves to summarize the current findings of herbal medicines combining with modern medicines in the area of fibrosis. It hopefully provides insights in further pharmaceutical research directions.
引用
收藏
页数:16
相关论文
共 167 条
[1]
Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals [J].
Aggarwal, Bharat B. .
ANNUAL REVIEW OF NUTRITION, VOL 30, 2010, 30 :173-199
[3]
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells [J].
Aleffi, S ;
Petrai, I ;
Bertolani, C ;
Parola, M ;
Colombatto, S ;
Novo, E ;
Vizzutti, F ;
Anania, FA ;
Milani, S ;
Rombouts, K ;
Laffi, G ;
Pinzani, M ;
Marra, F .
HEPATOLOGY, 2005, 42 (06) :1339-1348
[4]
Proteasome inhibition induces hepatic stellate cell apoptosis [J].
Anan, A ;
Baskin-Bey, ES ;
Bronk, SF ;
Werneburg, NW ;
Shah, VH ;
Gores, GJ .
HEPATOLOGY, 2006, 43 (02) :335-344
[5]
Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[6]
Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells [J].
Ankoma-Sey, V ;
Wang, Y ;
Dai, ZH .
HEPATOLOGY, 2000, 31 (01) :141-148
[7]
Burden of liver diseases in the world [J].
Asrani, Sumeet K. ;
Devarbhavi, Harshad ;
Eaton, John ;
Kamath, Patrick S. .
JOURNAL OF HEPATOLOGY, 2019, 70 (01) :151-171
[8]
Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review [J].
Bagherniya, Mohammad ;
Nobili, Valerio ;
Blesso, Christopher N. ;
Sahebkar, Amirhossein .
PHARMACOLOGICAL RESEARCH, 2018, 130 :213-240
[9]
Novel Engineered Targeted Interferon-gamma Blocks Hepatic Fibrogenesis in Mice [J].
Bansal, Ruchi ;
Prakash, Jai ;
Post, Eduard ;
Beljaars, Leonie ;
Schuppan, Detlef ;
Poelstra, Klaas .
HEPATOLOGY, 2011, 54 (02) :586-596
[10]
Alteration of AP-endonuclease1 expression in curcumin-treated fibrotic rats [J].
Bassiouny, Ahmad R. ;
Zaky, Amira ;
Fawky, Faten ;
Kandeel, Kamal M. .
ANNALS OF HEPATOLOGY, 2011, 10 (04) :516-530